IntegraGen announced unaudited revenue results for the full year 2022. The 2022 unaudited revenue amount to EUR 12,592,000 in 2022, representing an increase of 16% compared to 2021. This growth in all activities reflects the firmness of the company's positioning, both in terms of its main sequencing activities for R&D customers and its expertise in operating platforms on behalf of third parties.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.67 EUR | -2.90% | +8.06% | -25.06% |
01/05 | IntegraGen SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | IntegraGen SA Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-25.06% | 49.14L | |
-24.86% | 987.42Cr | |
-11.28% | 273.74Cr | |
-12.92% | 223.97Cr | |
-18.21% | 163.37Cr | |
+60.76% | 138.94Cr | |
+24.83% | 77Cr | |
-4.59% | 76Cr | |
-22.45% | 52Cr | |
-0.60% | 31Cr |
- Stock Market
- Equities
- ALINT Stock
- News IntegraGen
- IntegraGen Announces Unaudited Revenue Results for the Full Year 2022